A group of researchers at Washington State University has received four expressions of concern for papers whose findings underpin a publicly traded company founded by two of the most senior authors on the articles. The studies, all of which appeared in the Journal of Pharmacology and Experimental Therapeutics, came from the labs of Joseph Harding, … Continue reading Four papers by Athira CEO earn expressions of concern
A chemistry journal has retracted a 2014 paper by a group from China after the first author on the article copped to having Photoshopped a figure — marking the second retraction for members of the group in less than a week and the 14th for one of the authors. The paper, “Polymer nanodots of graphitic … Continue reading Highly cited paper marks 14th retraction for Chinese Academy of Sciences researcher
The authors of a paper taking a major database to task for including papers from allegedly predatory journals are objecting to the retraction of the article, which followed a request by one of the publishers mentioned in the analysis. And at least one of the journal’s editorial board members is considering resigning over the move. … Continue reading Authors object after Springer Nature journal cedes to publisher Frontiers’ demand for retraction
A paper that sought to bring some math to the idea that the spread of COVID-19 could be tracked in human excrement has been retracted because of the authors submitted it to two different Elsevier journals on the same day — and because of some eyebrow-raising behavior by the alleged peer reviewers. The first author … Continue reading COVID-19 wastewater tracking paper ends up in the sewer
What do aerobics and dance training have to do with geology? If that sounds like an odd question, take a look at more than 70 articles in a special collection of the Arabian Journal of Geosciences, published by Springer Nature, with titles such as:
A law firm known for filing shareholder suits says that data supporting a drug company’s plan for trials of its experimental treatment for Alzheimer’s disease show evidence of manipulation. Stock in the company, Cassava Biosciences, tumbled yesterday after the FDA posted material from the firm, Labaton Sucharow, and a top research integrity expert tells Retraction … Continue reading Biotech’s data supporting Alzheimer’s trials under scrutiny
A marketing journal is taking heat on social media for issuing an expression of concern over a 2019 paper that many readers believe should have been retracted — and correcting another instead of retracting it. The article now subject to an expression of concern, “Role of Ambient Temperature in Influencing Willingness to Pay in Auctions … Continue reading Readers puzzle over marketing journal’s failures to retract
A journal has issued expressions of concern for three papers from 2014 and 2015 by a group at Stony Brook University in New York whose work has come under scrutiny on PubPeer for suspect images. The articles, which appeared in the Journal of Neuroscience, were written by Adan Aguirre, a pharmacological scientist at Stony Brook, … Continue reading Neuroscientist’s work earns three expressions of concern
Two years after being alerted to a questionable figure in a 2016 paper by a group with a questionable publication history, a PLOS journal has issued an expression of concern about the article. The paper, “Deprivation of L-Arginine Induces Oxidative Stress Mediated Apoptosis in Leishmania donovani Promastigotes: Contribution of the Polyamine Pathway,” was published in … Continue reading Two years: That’s how long it took a PLOS journal to flag a paper after a sleuth raised concerns
A study that touted phototherapy as a way to combat the COVID-19 pandemic has been retracted after Elisabeth Bik noted a litany of concerns about the article, from duplications in the figures to the authors’ failure to disclose conflicts of interest. The article, “Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method … Continue reading Paper from company claiming phototherapy could treat COVID-19 is retracted